Jamey Hardesty, MPH

Medical Strategist


Jamey Hardesty, MPH

Jamey is an experienced medical strategist who develops patient and scientific strategies. His epidemiological experience includes international efforts in sub-saharan Africa researching HIV drug resistance and experience with the Chinese CDC. Prior to his role as a medical strategist, Jamey was a pandemic influenza epidemiologist with the Michigan Department of Health’s Communicable Diseases Division, where he monitored statewide surveillance and collaborated with the CDC on the management of the H1N1 influenza pandemic.

Jamey earned a master’s of public heath degree in Hospital and Molecular Epidemiology from the University of Michigan and a bachelor’s degree in microbiology and molecular genetics from Michigan State University. During this time he interned for the Michigan Department of Health and Human Services Bureau of Laboratories where he completed the first statewide survey of antibiotic resistance within Michigan hospitals. Currently, he is working on his MBA from the University at Albany in upstate New York.


Managed Markets, Patient Journey, Rare Disease, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Articles by Jamey Hardesty, MPH

Oncolytic Biosimilars: An Opportunity to Reduce Oncology Treatment Costs

Inclusion of oncology biosimilars in clinical pathways is one approach to reducing costs in this therapeutic area without compromising outcomes for cancer patients. There are currently eight Food and Drug Administration (FDA)-approved oncolytic biosimilars in the US market. Patients, providers, payers, policymakers, and manufacturers are all stakeholders that will be affected by these new biosimilars—and […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.